Advanced Medical Equipment
Abiomed Inc Reaffirms FY 2013 Revenue Guidance
Abiomed Inc maintained its fiscal 2014 revenue guidance in a range of $180 million to $185 million. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $184 million for fiscal 2014.
Natus Medical Inc Issues Q3 2013 Outlook; Revenue Outlook Below Analysts' Estimates; Issues Q4 2013 Outlook Below Analysts' Estimates; Lowers FY 2013 Outlook; Issues Q3 2013 Charge Outlook
Natus Medical Inc announced that for the third quarter 2013, it expects to report revenue of $80 million to $82 million and non-GAAP earnings per share of $0.18 to $0.21. For the fourth quarter 2013, the Company expects to report revenue of $84 million to $88 million and non-GAAP earnings per share...
Alliance HealthCare Services Inc Names Percy C. Tom Tomlinson, Jr. As Chief Executive Officer
Alliance HealthCare Services Inc announced that its Board of Directors has appointed Percy C. Tom Tomlinson, Jr., as Chief Executive Officer. Mr. Tomlinson will assume his new responsibilities and join the Board of Directors on October 1, 2013. Larry Buckelew, who serves as interim Chief Executive...
Alliance HealthCare Services Inc Reaffirms FY 2013 Guidance
Alliance HealthCare Services Inc announced that for fiscal 2013, the Company expects revenue to range from $450 million to $475 million and adjusted EBITDA to range from $140 million to $160 million.
Restructuring & Reorganization
Markets
- Sectors
- U.S.
- Europe
- Asia
Sector Summary
| Energy | |
| Basic Materials | |
| Industrials | |
| Cyclical Goods & Services | |
| Non-Cyclical Goods & Services | |
| Financials | |
| Healthcare | |
| Technology | |
| Telecoms | |
| Utilities |
| DOW | 15,628.02 | +0.83% | |
| S&P 500 | 1,706.87 | +1.25% | |
| NASDAQ | 3,675.74 | +1.36% | |
| TR US Index | 155.35 | +1.31% |
Upcoming Events
No related earnings announcements are currently scheduled within the next 7 days.
Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Renaissance Capital
|
$92.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

